(Albany, US) DelveInsight has launched a new report on “Hypothalamic Obesity – Market Insights, Epidemiology, and Market Forecast-2030“
DelveInsight’s “Hypothalamic Obesity – Market Insights, Epidemiology, and Market Forecast-2030“ report delivers an in-depth understanding of the Hypothalamic Obesity, historical and forecasted epidemiology as well as the Hypothalamic Obesity market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Some of the facts:
Request for free sample report: https://www.delveinsight.com/sample-request/hypothalamic-obesity-market
Scope of the reports:
Hypothalamic obesity refers to obesity that is caused by physical or inborn damage to the hypothalamus. The hypothalamus is part of the brain that makes hormones that control specific body functions such as sleep, body temperature, and hunger. It also makes hormones that control other organs in the body, especially the pituitary gland.
The symptoms of hypothalamic obesity vary by the cause and include
If the pituitary gland is involved, symptoms may include small underdeveloped testes in males and delayed puberty. This condition most often occurs because of injury to the hypothalamus due to a tumor, swelling in the brain, brain surgery, or head trauma. The diagnosis is made by physical examination and review of the symptoms. There is no cure for hypothalamic obesity. Treatment involves a combination of surgery, medications, and nutritional and lifestyle counselling.
Some of the Hypothalamic Obesity Companies Covered:
Hypothalamic Obesity Drugs Covered:
Table of Contents:
1. Key Insights
2. Executive Summary of Hypothalamic Obesity
3. Competitive Intelligence Analysis for Hypothalamic Obesity
4. Hypothalamic Obesity: Market Overview at a Glance
4.1. Hypothalamic Obesity Total Market Share (%) Distribution in 2017
4.2. Hypothalamic Obesity Total Market Share (%) Distribution in 2030
5. Hypothalamic Obesity: Disease Background and Overview
6. Patient Journey
7. Hypothalamic Obesity Epidemiology and Patient Population
8. Treatment Algorithm, Current Treatment, and Medical Practices
9. Unmet Needs
10. Key Endpoints of Hypothalamic Obesity Treatment
11. Marketed Products
List to be continued in report
12. Emerging Therapies
13. Hypothalamic Obesity: Seven Major Market Analysis
14. Attribute analysis
15. 7MM: Market Outlook
16. Access and Reimbursement Overview of Hypothalamic Obesity
17. KOL Views
18. Market Drivers
19. Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer
Request for detailed TOC: https://www.delveinsight.com/sample-request/hypothalamic-obesity-market
About DelveInsight
DelveInsight is a leading Life Science market research and business consulting company recognised for its off-the-shelf syndicated market research reports as well as customised solutions to firms in the healthcare sector.
Media ContactCompany Name: DelveInsight Business Research LLPContact Person: Ankit NigamEmail: Send EmailPhone: +19193216187Address:304 S. Jones Blvd #2432 City: AlbanyState: New YorkCountry: United StatesWebsite: https://www.delveinsight.com/report-store/hypothalamic-obesity-market